Works matching IS 14628732 AND DT 2011 AND VI 17 AND IP 2
1
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 173, doi. 10.1057/jcb.2010.37
- Kaufman, James;
- Kalaitzandonakes, Nicholas
- Article
5
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 201, doi. 10.1057/jcb.2011.1
- Article
8
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 195, doi. 10.1057/jcb.2011.8
- Schein, Michael;
- Fleischman, Brandon J
- Article
9
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 135, doi. 10.1057/jcb.2011.3
- Article
10
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 151, doi. 10.1057/jcb.2010.29
- Article
11
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 165, doi. 10.1057/jcb.2011.2
- Article
12
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 191, doi. 10.1057/jcb.2010.36
- Article
13
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 159, doi. 10.1057/jcb.2010.40
- Nieuwenhuizen, Peter J.;
- Lyon, David
- Article
14
- 2011
- Khalvati, Mohammadali;
- Michine, Ikway;
- Mukwa, Wabiska;
- Metatawabin, Mary Jane
- Opinion
15
- Journal of Commercial Biotechnology, 2011, v. 17, n. 2, p. 183, doi. 10.1057/jcb.2011.4
- Article